Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Inga Marijanović; Marija Kraljević; Teo Buhovac; Timur Cerić; Alma Mekić Abazović; Jasmina Alidžanović; Zdenka Gojković; Emir Sokolović

doi:10.12659/MSM.930812

19 April 2021 : Clinical Research

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Inga Marijanović^1ABDEF, Marija Kraljević^1ABDEF*, Teo Buhovac^1ABDEF, Timur Cerić^2BD, Alma Mekić Abazović^3BD, Jasmina Alidžanović^4BD, Zdenka Gojković^5BD, Emir Sokolović^6CD

DOI: 10.12659/MSM.930812

Med Sci Monit 2021; 27:e930812

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Relationship between levels of depression and levels of stress and anxiety among oncology staff in Bosnia and Herzegovina during the coronavirus disease 2019 pandemic.

Spearman’s rho		Anxiety	Stress
Depression	Correlation coefficient	0.448	0.536
	Sig. (2-tailed)	P<0.01	P<0.01
	N	175	175

Back to the Article

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic

Your Privacy